Navigation Links
NOVAVAX to Present at the Immunotherapeutics and Vaccine (IMVAC) Summit
Date:8/17/2010

ROCKVILLE, Md., Aug. 17 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that the company will be presenting at the IMVAC Summit. The Conference will take place August 17-19, 2010 at the Royal Sonesta Hotel, Cambridge, MA.  Dr. Steven Pincus will be presenting, "Influenza Virus-Like Particle Vaccine Produced in Insect Cells Elicits Hemagglutination and Neuraminidase Inhibiting Antibodies in Immunized Health Adults," on Tuesday, August 17, 2010, and Dr. Ramadevi Raghunandan, Senior Scientist, Immunology will be presenting, "Evaluation of the Safety and Efficacy of a Novel RSV F Particle Vaccine in the Cotton Rat," on Thursday, August 19, 2010.  

About Vaccine Forum Washington 2010

ImVacS brings together international vaccine leaders to discuss challenges and current breakthroughs in the world of vaccines. The four vaccine-focused meetings address innovating strategies to meet current health threats, changing technology for vaccine manufacture, top challenges faced during pre-clinical development, and progress underway for adjuvants and novel delivery systems. Altogether, ImVacS provides a snapshot of where vaccine development stands today. For more information, please see www.ImVacs.com.

About Novavax

Novavax, Inc. is a clinical-stage biotechnology company creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like-particle (VLP) technology.  The company produces potent VLP-based recombinant vaccines utilizing new and efficient manufacturing approaches.  Novavax is committed to using its VLP technology to create country-specific vaccine solutions.  The company has formed a joint venture with Cadila Pharmaceuticals, named CPL Biologicals, to develop and manufacture vaccines, biological therapeutics and diagnostics in India. Additional information about Novavax is available on the company's website: www.novavax.com.


'/>"/>
SOURCE Novavax, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. NOVAVAX Elects Richard H. Douglas to its Board of Directors
2. Novavax Announces Appointment of Dr. Gregory Glenn as Chief Scientific Officer
3. Novavax Announces Manufacturing Management Appointments
4. Novavax Announces Publication of a Pre-clinical Study with its Pandemic 2009 H1N1 Influenza Virus-Like Particle (VLP) Vaccine
5. NOVAVAX Completes Enrollment of Pivotal H1N1 Influenza Vaccine Clinical Trial in Mexico
6. NOVAVAX to Present at the 12th Annual BIO CEO & Investor Conference
7. NOVAVAX to Present at Phacilitate Vaccine Forum Washington 2010
8. NOVAVAX Announces Positive Preclinical Results for its Respiratory Syncytial Virus (RSV) Vaccine Candidate
9. NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference
10. NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults
11. Novavax Prices Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... OXFORD, England , May 23, 2016 ... Wednesday, May 25 th at 10:15 a.m. ET before ... about the role genetically engineered mosquitos can play in controlling ... known carrier of the Zika virus.      (Logo: ... genetically engineered male mosquito with a self-limiting gene. Trials in ...
(Date:5/22/2016)... ... ... Doctors in Rome say micronutrients found in certain foods have the potential ... just posted an article on the new research. Click here to read it ... Translational Medicine evaluated more than 150 studies on polyphenols in cancer for their report ...
(Date:5/20/2016)... ... May 20, 2016 , ... The recent recall by Costco ... by Food Safety News on May 12, 2016(1), demonstrates the need for faster and ... of Baltimore-based biotech firm, PathSensors, Inc. , PathSensor’s latest solution uses ...
(Date:5/19/2016)... (PRWEB) , ... May 19, 2016 , ... ... research organization (CRO) has welcomed Abu Siddiqui as Director, Large Molecule & Biomarker ... executing biologics, vaccine and translational biomarker discovery studies for preclinical and clinical safety ...
Breaking Biology Technology:
(Date:3/11/2016)... http://www.apimages.com ) - --> http://www.apimages.com ) - ... ( http://www.apimages.com ) - Germany . The ... refugee identity cards. DERMALOG will be unveiling this device, and a ... next week.   --> Germany . ... new refugee identity cards. DERMALOG will be unveiling this device, and ...
(Date:3/10/2016)... 10, 2016 --> ... report "Identity and Access Management Market by Component (Provisioning, ... Governance), by Organization Size, by Deployment, by Vertical, and ... MarketsandMarkets, The market is estimated to grow from USD ... 2020, at a Compound Annual Growth Rate (CAGR) of ...
(Date:3/9/2016)... , March 9, 2016 This BCC Research ... states of the RNA Sequencing (RNA Seq) market for ... as instruments, tools and reagents, data analysis, and services. ... segments of the RNA-Sequencing market such as RNA-Sequencing tools ... the main factors affecting each segment and forecast their ...
Breaking Biology News(10 mins):